94 related articles for article (PubMed ID: 10705481)
1. A new concise synthesis of arcyriacyanin A and its unique inhibitory activity against a panel of human cancer cell line.
Murase M; Watanabe K; Yoshida T; Tobinaga S
Chem Pharm Bull (Tokyo); 2000 Jan; 48(1):81-4. PubMed ID: 10705481
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and cytotoxicity of indolopyrrolemaleimides.
Xu GQ; Guo P; Zhang C; He QJ; Yang B; Hu YZ
Chem Pharm Bull (Tokyo); 2007 Sep; 55(9):1302-7. PubMed ID: 17827752
[TBL] [Abstract][Full Text] [Related]
3. Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3.
Zhang HC; White KB; Ye H; McComsey DF; Derian CK; Addo MF; Andrade-Gordon P; Eckardt AJ; Conway BR; Westover L; Xu JZ; Look R; Demarest KT; Emanuel S; Maryanoff BE
Bioorg Med Chem Lett; 2003 Sep; 13(18):3049-53. PubMed ID: 12941331
[TBL] [Abstract][Full Text] [Related]
4. Towards configurationally stable bisindolylmaleimide cyclophanes: potential tools for investigating protein kinase function.
Bartlett S; Nelson A
Chem Commun (Camb); 2004 May; (9):1112-3. PubMed ID: 15116210
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, and cytotoxic activity of N(ind)-alkoxy derivatives of antibiotic arcyriarubin and dechloro-rebeccamycin aglycon.
Lakatosh SA; Balzarini J; Andrei G; Snoeck R; Lakatosh A; De Clercq E; Preobrazhenskaya MN
J Antibiot (Tokyo); 2002 Aug; 55(8):768-73. PubMed ID: 12374389
[No Abstract] [Full Text] [Related]
6. Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 3: Importance of the indole orientation.
Lu Q; Chen Z; Perumattam J; Wang DX; Liang W; Xu YJ; Do S; Bonaga L; Higaki J; Dong H; Liclican A; Sideris S; Laney M; Dugar S; Mavunkel B; Levy DE
Bioorg Med Chem Lett; 2008 Apr; 18(7):2399-403. PubMed ID: 18337095
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of bisindolylmaleimides using a palladium catalyzed cross-coupling reaction.
Neel DA; Jirousek MR; McDonald JH
Bioorg Med Chem Lett; 1998 Jan; 8(1):47-50. PubMed ID: 9871626
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of novel bisindolylmaleimides that inhibit vascular endothelial cell proliferation.
Braña MF; Añorbe L; Tarrasón G; Mitjans F; Piulats J
Bioorg Med Chem Lett; 2001 Oct; 11(20):2701-3. PubMed ID: 11591505
[TBL] [Abstract][Full Text] [Related]
9. (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta.
Jirousek MR; Gillig JR; Gonzalez CM; Heath WF; McDonald JH; Neel DA; Rito CJ; Singh U; Stramm LE; Melikian-Badalian A; Baevsky M; Ballas LM; Hall SE; Winneroski LL; Faul MM
J Med Chem; 1996 Jul; 39(14):2664-71. PubMed ID: 8709095
[TBL] [Abstract][Full Text] [Related]
10. Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 1: SAR of the aryl region.
Levy DE; Wang DX; Lu Q; Chen Z; Perumattam J; Xu YJ; Liclican A; Higaki J; Dong H; Laney M; Mavunkel B; Dugar S
Bioorg Med Chem Lett; 2008 Apr; 18(7):2390-4. PubMed ID: 18334294
[TBL] [Abstract][Full Text] [Related]
11. A concise synthesis of a novel antiangiogenic tyrosine kinase inhibitor.
Payack JF; Vazquez E; Matty L; Kress MH; McNamara J
J Org Chem; 2005 Jan; 70(1):175-8. PubMed ID: 15624920
[TBL] [Abstract][Full Text] [Related]
12. Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 2: SAR of the amine tether.
Levy DE; Wang DX; Lu Q; Chen Z; Perumattam J; Xu YJ; Higaki J; Dong H; Liclican A; Laney M; Mavunkel B; Dugar S
Bioorg Med Chem Lett; 2008 Apr; 18(7):2395-8. PubMed ID: 18334295
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumor activity of bisindolylmaleimide and amino acid ester conjugates.
Wang K; Li XY; Chen XG; Liu ZZ
J Asian Nat Prod Res; 2010 Jan; 12(1):36-42. PubMed ID: 20390741
[TBL] [Abstract][Full Text] [Related]
14. One-pot synthesis of 2-substituted indoles from 2-aminobenzyl phosphonium salts. A formal total synthesis of arcyriacyanin A.
Kraus GA; Guo H
Org Lett; 2008 Jul; 10(14):3061-3. PubMed ID: 18572918
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
Showalter HD; Sercel AD; Leja BM; Wolfangel CD; Ambroso LA; Elliott WL; Fry DW; Kraker AJ; Howard CT; Lu GH; Moore CW; Nelson JM; Roberts BJ; Vincent PW; Denny WA; Thompson AM
J Med Chem; 1997 Feb; 40(4):413-26. PubMed ID: 9046331
[TBL] [Abstract][Full Text] [Related]
17. 3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3).
Smith DG; Buffet M; Fenwick AE; Haigh D; Ife RJ; Saunders M; Slingsby BP; Stacey R; Ward RW
Bioorg Med Chem Lett; 2001 Mar; 11(5):635-9. PubMed ID: 11266159
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
Tamir A; Granot Y; Isakov N
J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
[TBL] [Abstract][Full Text] [Related]
19. Studies on protein kinase C inhibitors; structure-activity relationships in indolocarbazole and bis-indole series.
Fabre S; Prudhomme M; Rapp M
Bioorg Med Chem; 1993 Sep; 1(3):189-92. PubMed ID: 8081851
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and cytotoxic activities of a series of novel N-methyl-bisindolylmaleimide amide derivatives.
Wang K; Liu ZZ
J Asian Nat Prod Res; 2014; 16(3):296-303. PubMed ID: 24456252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
